ERBB2 and breast carcinoma: Rodriguez-Bathe rrueco et al, demonstrated that S100A8/9 is induced following the activation of the STAT3 pathway, and that it promotes the proliferation of HER2-negative/HER2-positive breast cancer cells (19).